FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
Not yet recruiting · NCT00424866 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease | Arterial Occlusive Diseases, Constriction, Pathologic, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-19 | NCT00424866 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Venturis Therapeutics, Inc. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Venturis Therapeutics | Chicago | United States | 1 |